Sheryar Afzal

1.1k total citations · 2 hit papers
38 papers, 706 citations indexed

About

Sheryar Afzal is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Sheryar Afzal has authored 38 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Sheryar Afzal's work include Adipokines, Inflammation, and Metabolic Diseases (8 papers), Adipose Tissue and Metabolism (6 papers) and Medicinal Plants and Neuroprotection (3 papers). Sheryar Afzal is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (8 papers), Adipose Tissue and Metabolism (6 papers) and Medicinal Plants and Neuroprotection (3 papers). Sheryar Afzal collaborates with scholars based in Malaysia, Saudi Arabia and Nigeria. Sheryar Afzal's co-authors include Ali Attiq, Mahmoud Kandeel, Ibrahim Albokhadaim, Sameer Alhojaily, Aimi Syamima Abdul Manap, Aqeel Javeed, Amjad Riaz, Muhammad M. Mukhtar, Waqas Ahmad and Aamir Ghafoor and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Sheryar Afzal

33 papers receiving 693 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration

2023 177 citations Sheryar Afzal, Aimi Syamima Abdul Manap et al. Frontiers in Pharmacology profile →
Hegemony of inflammation in atherosclerosis and coronary artery disease

2024 87 citations Ali Attiq, Sheryar Afzal et al. European Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheryar Afzal Malaysia	12	201	116	114	84	75	38	706
Khaled Alhosaini Saudi Arabia	16	278 1.4×	130 1.1×	85 0.7×	57 0.7×	53 0.7×	44	794
Joanne M. Dennis Australia	14	267 1.3×	149 1.3×	41 0.4×	93 1.1×	53 0.7×	22	816
Shunhe Wang China	15	385 1.9×	108 0.9×	58 0.5×	101 1.2×	72 1.0×	31	762
Zihui Zhang China	19	497 2.5×	145 1.3×	78 0.7×	75 0.9×	109 1.5×	64	989
Anna Bogacz Poland	15	296 1.5×	68 0.6×	107 0.9×	53 0.6×	117 1.6×	102	919
Nermin Abdel Hamid Sadik Egypt	21	421 2.1×	92 0.8×	76 0.7×	94 1.1×	84 1.1×	53	1.2k
Chenlong Wang China	14	421 2.1×	133 1.1×	138 1.2×	53 0.6×	27 0.4×	29	835
Ting‐Lin Yen Taiwan	17	389 1.9×	78 0.7×	64 0.6×	73 0.9×	57 0.8×	49	939
Jia Song China	14	226 1.1×	101 0.9×	35 0.3×	67 0.8×	68 0.9×	37	568
Belal Chami Australia	14	286 1.4×	209 1.8×	55 0.5×	148 1.8×	37 0.5×	35	787

Countries citing papers authored by Sheryar Afzal

Since Specialization

Citations

This map shows the geographic impact of Sheryar Afzal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheryar Afzal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheryar Afzal more than expected).

Fields of papers citing papers by Sheryar Afzal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheryar Afzal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheryar Afzal. The network helps show where Sheryar Afzal may publish in the future.

Co-authorship network of co-authors of Sheryar Afzal

This figure shows the co-authorship network connecting the top 25 collaborators of Sheryar Afzal. A scholar is included among the top collaborators of Sheryar Afzal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheryar Afzal. Sheryar Afzal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Attiq, Ali, et al.. (2025). Neuroinflammation to neurodegeneration: Boulevard of broken nerves. International Immunopharmacology. 161. 115015–115015. 1 indexed citations

Mahmoud, Nuha, Nazlina Ibrahim, Ibrahim Albokhadaim, et al.. (2025). Exploring varicella zoster virus proteome for construction and validation of a multi-epitope based subunit vaccine using multifaceted immunoinformatics approaches. PLoS ONE. 20(6). e0324453–e0324453. 1 indexed citations

Attiq, Ali, Sheryar Afzal, Habibah A. Wahab, et al.. (2024). Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches. Drug Design Development and Therapy. Volume 18. 4215–4240. 6 indexed citations

Tan, Sang Loon, Nafees Ahemad, Azzmer Azzar Abdul Hamid, et al.. (2024). Molecular docking and dynamics simulation reveal withanolides as potent antivirals against dengue virus. South African Journal of Botany. 169. 426–434. 2 indexed citations

Afzal, Sheryar, et al.. (2024). <i>In vitro</i> cytotoxic activity of <i>Sansevieria trifasciata</i> against various cancer cell lines. Tropical Journal of Pharmaceutical Research. 23(3). 491–499. 1 indexed citations

Kandeel, Mahmoud, et al.. (2024). Revolutionizing Antiviral Drug Discovery: The Emerging Role of Artificial Intelligence. International Journal of Pharmacology. 20(4). 536–546. 1 indexed citations

Afzal, Sheryar, et al.. (2024). A comprehensive review on chemical and pharmacological potential of Synsepalum dulcificum (Schumach. & Thonn.) Daniell. Boletin Latinoamericano y del Caribe de plantas Medicinales y Aromaticas. 23(5). 706–731.

Afzal, Sheryar, Yuan Seng Wu, Aimi Syamima Abdul Manap, et al.. (2024). In vitro antimicrobial and cytotoxic potential against colorectal cancer cell lines using ethanolic leaf extract of Sansevieria trifasciata (Agavaceae). Indian Journal of Pharmacology. 56(5). 329–334. 1 indexed citations

Attiq, Ali, Sheryar Afzal, Waqas Ahmad, & Mahmoud Kandeel. (2024). Hegemony of inflammation in atherosclerosis and coronary artery disease. European Journal of Pharmacology. 966. 176338–176338. 87 indexed citations breakdown →

10.

Afzal, Sheryar, Aimi Syamima Abdul Manap, Ali Attiq, et al.. (2023). From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Frontiers in Pharmacology. 14. 1269581–1269581. 177 indexed citations breakdown →

11.

Attiq, Ali & Sheryar Afzal. (2023). Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment. Frontiers in Pharmacology. 14. 1255727–1255727. 9 indexed citations

12.

Afzal, Sheryar, Munavvar Abdul Sattar, Olorunfemi A. Eseyin, Ali Attiq, & Edward J. Johns. (2021). Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs. European Journal of Pharmacology. 917. 174703–174703. 4 indexed citations

13.

Afzal, Sheryar, Munavvar Abdul Sattar, Edward J. Johns, & Olorunfemi A. Eseyin. (2020). Renoprotective and haemodynamic effects of adiponectin and peroxisome proliferator-activated receptor agonist, pioglitazone, in renal vasculature of diabetic Spontaneously hypertensive rats. PLoS ONE. 15(11). e0229803–e0229803. 9 indexed citations

14.

Eseyin, Olorunfemi A., et al.. (2018). GC-MS and HPLC profiles of phenolic fractions of the leaf of Telfairia occidentalis.. PubMed. 31(1). 45–50. 12 indexed citations

15.

Ahmad, Ashfaq, Munavvar Zubaid Abdul Sattar, Hassaan Anwer Rathore, et al.. (2016). ANTIOXIDANT ACTIVITY AND FREE RADICAL SCAVENGING CAPACITY OF L-ARGININE AND NAHS: A COMPARATIVE IN VITRO STUDY.. PubMed. 72(2). 245–52. 21 indexed citations

16.

Afzal, Sheryar, et al.. (2016). Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats. Journal of Physiology and Biochemistry. 72(4). 593–604. 14 indexed citations

17.

Rathore, Hassaan Anwer, et al.. (2015). A critical review of pharmacological significance of Hydrogen Sulfide in hypertension. Indian Journal of Pharmacology. 47(3). 243–243. 23 indexed citations

18.

Afzal, Sheryar, Munavvar Abdul Sattar, Hassaan Anwer Rathore, et al.. (2013). ADIPONECTIN VERSUS THIAZOLIDINEDIONES AND ANGIOTENSIN RECEPTOR BLOCKERS. European Scientific Journal ESJ. 9(24). 1 indexed citations

19.

Ali, Aftab, et al.. (2012). PHARMACOKINETIC STUDY OF KETOPROFEN IN HEALTHY SHEEP UNDER LOCAL CONDITIONS OF PAKISTAN. The Journal of Animal and Plant Sciences. 22(3). 588–592. 3 indexed citations

20.

Javeed, Aqeel, Muhammad Ashraf, Amjad Riaz, et al.. (2009). Paclitaxel and immune system. European Journal of Pharmaceutical Sciences. 38(4). 283–290. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact